NCT04786938View on ClinicalTrials.gov

Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

June 9, 2017

Study Completion Date

June 9, 2017

Conditions

Gut Resistome

Interventions

DRUG

Saccharomyces Boulardii-Containing Product in Oral Dose Form

S. boulardii CNCM I-745 (approximately 22.5 x109 CFU)

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Universidad Tecnológica Equinoccial

OTHER

collaborator

Biocodex

INDUSTRY

lead

Universidad San Francisco de Quito

OTHER

NCT04786938 - Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy | Biotech Hunter | Biotech Hunter